Structural remodeling in the limb circulation: Impact of obesity and diabetes

Microcirculation

Volumn 14, Issue 4-5, 2007, Pages 311-316

  Stepp, David W ^a   Belin De Chantemele, Eric J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

CLI; Microvascular; Obese

Indexed keywords

ARTERIOLE; ATHEROSCLEROSIS; BASEMENT MEMBRANE; BLOOD VESSEL WALL; DISEASE COURSE; DISEASE MODEL; HUMAN; INSULIN RESISTANCE; LIMB DISEASE; LIMB ISCHEMIA; MEMBRANE STRUCTURE; METABOLIC DISORDER; MICROCIRCULATION; MICROVASCULARIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; VASCULAR RESISTANCE;

ANIMALS; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; EXTREMITIES; HUMANS; MICROCIRCULATION; OBESITY;

ANIMALIA;

EID: 34447300961     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/10739680701285609     Document Type: Review

References (50)

1. Bakker, E. N., Buus, C. L., Spaan, J. A., Perree, J., Ganga, A., Rolf, T. M., Sorop, O., Bramsen, L. H., Mulvany, M. J. and Vanbavel, E. (2005) Small artery remodeling depends on tissue-type transglutaminase. Circ Res, 96, pp. 119-126.
2. Beisswenger, P. J., Moore, L. L., Brinck-Johnsen, T. and Curphey, T. J. (1993) Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest, 92, pp. 212-217.
3. Bohlen, H. G. and Niggl, B. A. (1979) Adult microvascular disturbances as a result of juvenile onset diabetes in Db/Db mice. Blood Vessels, 16, pp. 269-276.
4. Brownlee, M. (1992) Glycation products and the pathogenesis of diabetic complications. Diabetes Care, 15, pp. 1835-1843.
5. Buus, C. L., Pourageaud, F., Fazzi, G. E., Janssen, G., Mulvany, M. J. and De Mey, J. G. (2001) Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries. Circ Res, 89, pp. 180-186.
6. Cameron, N. E. and Cotter, M. A. (1997) Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes, 46, pp. S31-S37.
7. Cameron, N. E., Eaton, S. E., Cotter, M. A. and Tesfaye, S. (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia, 44, pp. 1973-1988.
8. Ceiler, D. L. and De Mey, J. G. (2000) Chronic N(G)-nitro-L-arginine methyl ester treatment does not prevent flow-induced remodeling in mesenteric feed arteries and arcading arterioles. Arterioscler Thromb Vasc Biol, 20, pp. 2057-2063.
9. Chappey, O., Dosquet, C., Wautier, M. P. and Wautier, J. L. (1997) Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest, 27, pp. 97-108.
10. Clark, M. G., Rattigan, S., Clerk, L. H., Vincent, M. A., Clark, A. D., Youd, J. M. and Newman, J. M. (2000) Nutritive and non-nutritive blood flow: Rest and exercise. Acta Physiol Scand, 168, pp. 519-530.
11. Cleland, S. J., Petrie, J. R., Ueda, S., Elliott, H. L. and Connell, J. M. (1998) Insulin as a vascular hormone: Implications for the pathophysiology of cardiovascular disease. Clin Exp Pharmacol Physiol, 25, pp. 175-184.
12. Coats, P. (2003) Myogenic, mechanical and structural characteristics of resistance arterioles from healthy and ischaemic subjects. Clin Sci (Lond), 105, pp. 683-689.
13. Corman, B., Duriez, M., Poitevin, P., Heudes, D., Bruneval, P., Tedgui, A. and Levy, B. I. (1998) Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci USA, 95, pp. 1301-1306.
14. Davy, K. P. and Hall, J. E. (2004) Obesity and hypertension: Two epidemics or one?. Am J Physiol Regul Integr Comp Physiol, 286, pp. R803-R813.
15. Dosluoglu, H. H., O'Brien-Irr, M. S., Lukan, J., Harris, L. M., Dryjski, M. L. and Cherr, G. S. (2006) Does preferential use of endovascular interventions by vascular surgeons improve limb salvage, control of symptoms, and survival of patients with critical limb ischemia?. Am J Surg, 192, pp. 572-576.
16. Dumont, O., Loufrani, L. and Henrion, D. (2007) Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries. Arterioscler Thromb Vasc Biol, 27, pp. 317-324.
17. Flynn, M. D. and Tooke, J. E. (1992) Aetiology of diabetic foot ulceration: A role for the microcirculation?. Diabet Med, 9, pp. 320-329.
18. Flynn, M. D. and Tooke, J. E. (1995) Diabetic neuropathy and the microcirculation. Diabet Med, 12, pp. 298-301.
19. Frisbee, J. C. (2005) Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol, 289, pp. R307-R316.
20. Frisbee, J. C., Samora, J. B., Peterson, J. and Bryner, R. (2006) Exercise training blunts microvascular rarefaction in the metabolic syndrome. Am J Physiol Heart Circ Physiol, 291, pp. H2483-H2492.
21. Fulton, D., Harris, M. B., Kemp, B. E., Venema, R. C., Marrero, M. B. and Stepp, D. W. (2004) Insulin resistance does not diminish eNOS expression, phosphorylation or binding to hsp90. Am J Physiol Heart Circ Physiol, 287:6, p. H2384.
22. Garcia, L. A. (2006) Epidemiology and pathophysiology of lower extremity peripheral arterial disease. J Endovasc Ther, 13, pp. II3-II9.
23. Goldenberg, S., Alex, M., Joshi, R. A. and Blumenthal, H. T. (1959) Nonatheromatous peripheral vascular disease of the lower extremity in diabetes mellitus. Diabetes, 8, pp. 261-273.
24. Goldin, A., Beckman, J. A., Schmidt, A. M. and Creager, M. A. (2006) Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation, 114, pp. 597-605.
25. Greenwald, S. (2007) Ageing of the conduit arteries. J Pathol, 211, pp. 157-172.
26. Hillier, C., Sayers, R. D., Watt, P. A., Naylor, R., Bell, P. R. and Thurston, H. (1999) Altered small artery morphology and reactivity in critical limb ischaemia. Clin Sci (Lond), 96, pp. 155-163.
27. Howard Jr., C. F. (1975) Basement membrane thickness in muscle capillaries of normal and spontaneously diabetic Macaca nigra. Diabetes, 24, pp. 201-206.
28. Hummel, K. P., Coleman, D. L. and Lane, P. W. (1972) The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL-6J strains. Biochem Genet, 7, pp. 1-13.
29. Kass, D. A., Shapiro, E. P., Kawaguchi, M., Capriotti, A. R., Scuteri, A., de Groof, R. C. and Lakatta, E. G. (2001) Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation, 104, pp. 1464-1470.
30. Kim, J. A., Montagnani, M., Koh, K. K. and Quon, M. J. (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation, 113, pp. 1888-1904.
31. Ford, E. S., McGuire, L. C. and Mokdad, A. H. (2007) Increasing trends in waist circumference and abdominal obesity among U.S. adults. Obesity (Silver Spring), 15, pp. 216-224.
32. Mather, K., Anderson, T. J. and Verma, S. (2001) Insulin action in the vasculature: Physiology and pathophysiology. J Vasc Res, 38, pp. 415-422.
33. McMillan, D. E. (1975) Deterioration of the microcirculation in diabetes. Diabetes, 24, pp. 944-957.
34. Piiper, J. (1992) Modeling of oxygen transport to skeletal muscle: Blood flow distribution, shunt, and diffusion. Adv Exp Med Biol, 316, pp. 3-10.
35. Rask-Madsen, C. and King, G. L. (2007) Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab, 3, pp. 46-56.
36. Reddy, G. K. (2004) AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc Res, 68, pp. 132-142.
37. Schramm, J. C., Dinh, T. and Veves, A. (2006) Microvascular changes in the diabetic foot. Int J Low Extrem Wounds, 5, pp. 149-159.
38. Schwartz, E. A. and Reaven, P. D. (2006) Molecular and signaling mechanisms of atherosclerosis in insulin resistance. Endocrinol Metab Clin North Am, 35, pp. 525-549.
39. Semenkovich, C. F. (2006) Insulin resistance and atherosclerosis. J Clin Invest, 116, pp. 1813-1822.
40. Shammas, N. W. and Dippel, E. J. (2005) Evidence-based management of peripheral vascular disease. Curr Atheroscler Rep, 7, pp. 358-363.
41. Shankar, S. S., Considine, R. V., Gorski, J. C. and Steinberg, H. O. (2006) Insulin sensitivity is preserved despite disrupted endothelial function. Am J Physiol Endocrinol Metab, 291, pp. E691-E696.
42. Stacy, D. L. and Prewitt, R. L. (1989) Effects of chronic hypertension and its reversal on arteries and arterioles. Circ Res, 65, pp. 869-879.
43. Stepp, D. W. (2006) Impact of obesity and insulin resistance on vasomotor tone: Nitric oxide and beyond. Clin Exp Pharmacol Physiol, 33, pp. 407-414.
44. Stepp, D. W., Pollock, D. M. and Frisbee, J. C. (2004) Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol, 286, pp. H964-H970.
45. Strandness Jr., D. E., Priest, R. E. and Gibbons, G. E. (1964) Combined clinical and pathologic study of diabetic and nondiabetic peripheral arterial disease. Diabetes, 13, pp. 366-372.
46. Striker, L. J. and Striker, G. E. (1996) Administration of AGEs in vivo induces extracellular matrix gene expression. Nephrol Dial Transplant, 11, pp. 62-65.
47. Ueda, S., Petrie, J. R., Cleland, S. J., Elliott, H. L. and Connell, J. M. (1998) Insulin vasodilatation and the "arginine paradox". Lancet, 351, pp. 959-960.
48. Ueda, S., Petrie, J. R., Cleland, S. J., Elliott, H. L. and Connell, J. M. (1998) The vasodilating effect of insulin is dependent on local glucose uptake: A double blind, placebo-controlled study. J Clin Endocrinol Metab, 83, pp. 2126-2131.
49. Williamson, J. R., Vogler, N. J. and Kilo, C. (1971) Regional variations in the width of the basement membrane of muscle capillaries in man and giraffe. Am J Pathol, 63, pp. 359-370.
50. Zhou, Y. P., Cockburn, B. N., Pugh, W. and Polonsky, K. S. (1999) Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: Role of enhanced fuel metabolism. Metabolism, 48, pp. 857-864.